{'fraction_non_alphanumeric': 0.014830508474576272, 'fraction_numerical': 0.00211864406779661, 'mean_word_length': 5.654929577464789, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Therapeutic Choices in the Treatment of Acute Community-Acquired Bacterial Rhinosinusitis

Background Acute bacterial rhinosinusitis (ABRS) is a common medical problem affecting a large percentage of the population. The disease will most often follow a viral upper respiratory tract infection. Methods Appropriately diagnosed, ABRS is best treated with antibiotics, but other medications may play a role in some circumstances. Increasing antibiotic resistance to the common bacteria causing ABRS has occurred in the past 20 years, driven largely by inappropriate or unnecessary antibiotic use. Results There are many antibiotics available that may be used for the treatment of ABRS. The selection of the best antibiotic option is determined by evaluating a number of factors, with the potential antibiotic resistance being an important consideration. Conclusion This article reviews current recommendations for the antibiotic treatment of ABRS.